de Jong LAA - Search Results

1

Assessment of medication use during pregnancy by Web-based questionnaires, pharmacy records and serum screening.

van Gelder MMHJ, de Jong LAA, Te Winkel B, Olyslager EJH, Vorstenbosch S, van Puijenbroek EP, Verbeek ALM, Roeleveld N. van Gelder MMHJ, et al. Among authors: de jong laa. Reprod Toxicol. 2019 Mar;84:93-97. doi: 10.1016/j.reprotox.2019.01.002. Epub 2019 Jan 4. Reprod Toxicol. 2019. PMID: 30615926 Free article.

2

The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands.

de Jong LAA, Olyslager EJH, Duijst WLJM. de Jong LAA, et al. J Forensic Leg Med. 2019 Jul;65:101-104. doi: 10.1016/j.jflm.2019.05.011. Epub 2019 May 21. J Forensic Leg Med. 2019. PMID: 31129558

3

Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assay.

de Jong LA, Verwey B, Essink G, Muntendam A, Zitman FG, Ensing K. de Jong LA, et al. J Anal Toxicol. 2004 Oct;28(7):587-92. doi: 10.1093/jat/28.7.587. J Anal Toxicol. 2004. PMID: 15516318

4

Bioelectrical Impedance Measurements for Assessment of Kidney Function in Critically Ill Patients.

de Jong LAA, Otten-Helmers AG, Spronk PE, van Kan HJM. de Jong LAA, et al. Crit Care Med. 2019 Dec;47(12):e984-e992. doi: 10.1097/CCM.0000000000004033. Crit Care Med. 2019. PMID: 31609770

5

Development and validation of a radioreceptor assay for the determination of morphine and its active metabolites in serum.

de Jong LA, Krämer K, Kroeze MP, Bischoff R, Uges DR, Franke JP. de Jong LA, et al. J Pharm Biomed Anal. 2005 Oct 4;39(5):964-71. doi: 10.1016/j.jpba.2005.04.049. Epub 2005 Jun 27. J Pharm Biomed Anal. 2005. PMID: 15985356

6

Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the beta-adrenergic receptor.

de Jong LA, Jeronimus-Stratingh CM, Cremers TI. de Jong LA, et al. Rapid Commun Mass Spectrom. 2007;21(4):567-72. doi: 10.1002/rcm.2869. Rapid Commun Mass Spectrom. 2007. PMID: 17245793

7

Receptor-ligand binding assays: technologies and applications.

de Jong LA, Uges DR, Franke JP, Bischoff R. de Jong LA, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Dec 27;829(1-2):1-25. doi: 10.1016/j.jchromb.2005.10.002. Epub 2005 Oct 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 16253574

8

Improving the performance of glutamate microsensors by purification of ascorbate oxidase.

Oldenziel WH, de Jong LA, Dijkstra G, Cremers TI, Westerink BH. Oldenziel WH, et al. Anal Chem. 2006 Apr 1;78(7):2456-60. doi: 10.1021/ac051958l. Anal Chem. 2006. PMID: 16579635

9

Prolonged Ketamine and Norketamine Excretion Profiles in Urine After Chronic Use: A Case Series.

de Jong LAA, Qurishi R, Stams MPJ, Böttcher M, de Jong CAJ. de Jong LAA, et al. J Clin Psychopharmacol. 2020 May/Jun;40(3):300-304. doi: 10.1097/JCP.0000000000001191. J Clin Psychopharmacol. 2020. PMID: 32332467

10

Purification and characterization of the recombinant human dopamine D2S receptor from Pichia pastoris.

de Jong LA, Grünewald S, Franke JP, Uges DR, Bischoff R. de Jong LA, et al. Protein Expr Purif. 2004 Feb;33(2):176-84. doi: 10.1016/j.pep.2003.08.018. Protein Expr Purif. 2004. PMID: 14711504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters